LOS ANGELES, Oct. 06, 2017 -- Kange Corp, whose symbol (KGNR) is proud to provide a Shareholder update as to our progress in pursuit of our Business Plan.
On October 2nd 2017 Kange Corp entered into a LOI with John Textor and Evolution/AI Corporation to explore the possibility of an Acquisition of their Technology and Assets. Mr. Textor stated:
“Evolution AI is a developer of Hyper- Realistic Digital Humans and related Technology of Interactive Artificial Intelligence Applications.”
Mr. Textor was and is involved with the groundbreaking and believable Digital Humans such as the Tupac Hologram, Virtual Michael Jackson and The Academy Award Winning character Benjamin Button.
Dr. Malone stated “ I am excited for the opportunity to explore a working relationship with such established Individuals and hopeful that the Vision of Evolution AI and Kange Corp will come together as one.”
We shall keep all our Shareholders abreast as we continue forward.
About Kange
Kange Corp. (“Kange,” the “Company,” “we,” “us,” or ”our”) was incorporated under the laws of the State of Nevada on August 16, 2013 (Inception). We are a development stage company developing mobile software products, for Apple and Android platforms, starting in Estonia and Europe, which is our initial intended market. Apple is a trademark of Apple Inc., and Android is a trademark of Alphabet Inc.
Forward-Looking Statements
Cautionary language regarding Forward-Looking Statements Safe Harbor Act Disclaimer: Forward looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Certain statements in this press release, including projections results of operations, may contain words such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "projects," "plans," "targets" and other similar language and are considered forward-looking statements. These statements are based on management's current expectations, estimates, and forecasts. These forward-looking statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and therefore the actual results may be materially different from those discussed.
Investor Relations Contact:
Dr. Art Malone Jr (818) 878-9346


Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 



